Formulation and Evaluation of Herbal Pastilles for Tobacco and Smoking De-addiction

The Global Crisis of Tobacco and Smoking,   

Tobacco addiction is a critical global health em+ergency and the leading cause of preventable death and disease worldwide. India currently stands as the second-largest manufacturer and consumer of tobacco products globally. Chronic tobacco use, whether through smoking or smokeless forms, is a primary predisposing factor for life-threatening conditions, including various malignant neoplasms (cancers), cardiovascular diseases, and chronic respiratory tract infections such as COPD, emphysema, and bronchiti

The addictive nature of tobacco is driven by nicotine, which creates both a physical and psychological dependency. While many users express a desire to quit, the sudden cessation of tobacco leads to debilitating withdrawal symptoms. These symptoms include intense cravings, irritability, anxiety, restlessness, insomnia, and nausea  [1-4] 

Limitations of Current Treatments    

Currently, several medicinal and behavioral methods are used to aid cessation, but they often face significant challenges:   

• Nicotine Replacement Therapy (NRT): Options like patches, gums, and sprays provide a controlled dose of nicotine but often fail to achieve long-term success for the majority of smokers.   
• Pharmacological Treatments: While effective in alleviating withdrawal, prescription drugs are frequently expensive and carry a risk of numerous potential side effects.   
• Therapeutic Non-compliance: Many patients fail to follow treatment regimens due to the unpleasant taste of medications, adverse effects, or difficulty swallowing pills.   

There is a clear and urgent need for a nicotine-free, cost-effective, and palatable formulation that not only helps in de-addiction but also treats the physical ailments, such as oral lesions, caused by tobacco use.[5-8]    

The Proposed Solution: Polyherbal Pastilles    

This project proposes the formulation of medicated herbal pastilles as a patient-friendly and effective alternative for de-addiction. Pastilles are solid oral medications designed to dissolve slowly in the buccal cavity (mouth).   

The use of a pastille dosage form offers several strategic benefits for a person trying to quit tobacco:   

• Oral Fixation: By dissolving slowly (averaging 10 ± 2 minutes), the pastille satisfies the "hand to mouth" urge and oral cravings that smokers experience.   
• Local and Systemic Healing: The pastille provides a topical effect to promote the healing of oral mucosal lesions while also delivering systemic benefits through absorption.   
• Convenience: Pastilles are non-invasive, portable, and do not require water for ingestion, which significantly increases patient compliance. [9-10]  

Rationale for Ingredient Selection    

Our formulation utilizes a synergistic blend of four standardized herbal extracts, each chosen for a specific pharmacological role in the de-addiction process    

Table no.1: List of Crude drugs with its Benefit

All these 4 ingredients were used to replace the nicotine [11-15]         

MATERIALS AND METHODS

Study Rationale and Delivery System

A medicated pastille (similar to a gummy lozenge) was chosen as the best way to deliver this treatment because it works in two ways at once: it treats the mouth directly and enters the bloodstream for overall relief. 

• Long-Lasting Effect: While pills are swallowed quickly, these pastilles stay in the mouth for about 10 minutes. 
• Satisfies Cravings: This long "staying time" helps smokers who miss the habit of having something in their mouth (known as oral fixation). 
• Direct Healing: Because the pastille dissolves slowly, ingredients like Clove and Curcumin have more time to directly coat and heal mouth sores or lesions caused by tobacco use. 

Formulation Composition

The formulation utilizes a synergistic polyherbal blend consisting of Ashwagandha (adaptogen), Ginger (anti-emetic), Clove (sensory substitute), and Curcumin (mucosal repair). These active extracts were incorporated into a candy-like matrix. 

Table 1: List of Ingredients and Their Pharmaceutical Roles

Ashwagandha                                                Clove

Curcumin                                                                 Ginger

Manufacturing Process

The "Heating and Congealing" technique was employed for manufacturing. This method creates a stable, palatable matrix that ensures uniform drug distribution and high patient compliance without requiring water for administration. 

Instrumentation and Evaluation

The formulation and evaluation were conducted using standardized laboratory equipment:

• Formulation: Beakers, glass rods, and temperature-controlled water baths were used for the indirect heating of the gelatin-sucrose base. 
• Evaluation:
  • Analytical Balance: Used for precision weighing of extracts.  o            pH Meter: Calibrated to ensure compatibility with oral mucosa (pH ~5.5).          o Dissolution Tester:

Employed to determine the drug release profile in phosphate buffer. 

• • UV-Spectrophotometer: Used for quantitative analysis and concentration determination at

$\lambda_{max}$ 325nm.

Extraction of Bioactives

To maximize the concentration of secondary

metabolites, a two-step exhaustive extraction process was utilized: 

• Maceration: Ground herbal materials were soaked in a hydroalcoholic solvent (Ethanol/Methanol) for three days to facilitate cell swelling and the slow diffusion of active compounds like withanolides and gingerols. 
• Soxhlet Extraction: Continuous extraction was performed using a Soxhlet apparatus, a standard technique for recovering phytochemicals from ginger, ashwagandha, turmeric, and clove. 
• Methodology: Dried powder was placed in a thimble and processed with appropriate solvents (ethanol, methanol, or acetone) through 10–20 siphon cycles over 2–4 days at boiling temperature. 
• Concentration: The resulting solvent was evaporated to obtain the final concentrated extracts and essential oils.

Soxhlet Extraction of Curcumin

Maceration

Formulation of Herbal Pastilles

The pastilles were manufactured using the heating and congealing method according to the following standardized procedure: 

1. Base Preparation: 20 mL of distilled water was heated under continuous stirring to form a thick paste. 
2. 
   Matrix Incorporation: Liquid glucose, gelatin, and citric acid were added to the mixture to establish the gelling matrix. 
3. Additive Addition: After partial cooling, orange oil, peppermint oil, and food-grade color were incorporated. 
4. Moulding: The mixture was poured into moulds pre-coated with liquid paraffin to prevent sticking. 
5. Setting: The units were allowed to set at room temperature for 20–30 minutes, resulting in the formation of 10–14 jelly-like pastille units. 

Table no.: Formulation Table of Pastilles (Batches):

Table no.5: optimization Observations

RESULTS AND DISCUSSION

The polyherbal pastilles were evaluated for physicochemical and phytochemical parameters to ensure quality, stability, and therapeutic efficacy. 

Physicochemical Evaluation

• pH Stability: The pastilles maintained a pH of 5.5, which is ideal for the oral mucosa and prevents irritation during consumption. 
• Dissolution Profile: In-vitro drug release reached 96% within 30 minutes, confirming a consistent and controlled release of active constituents. 
• Weight & Thickness: The average weight was 2.36 g and average thickness was 3.2 mm, demonstrating uniform drug distribution and batch consistency. 
• Stability: Under accelerated conditions ($40^\circ\text{C}$), the formulation remained robust with drug content held between 95%–100% after 30 days. 

Table 1: Stability and Physical Parameters Summary

 Phytochemical Screening and Therapeutic Role

Phytochemical analysis confirmed the presence of key secondary metabolites in all herbal extracts, which are essential for treating nicotine dependence. 

Table 2: Phytochemical Profile and Clinical Rationale